U.S. Capital Markets Stock News

Expedia Group (EXPE) is back in focus after a packed Q1 2026 update, combining earnings, fresh guidance, a new US$5b buyback plan and a US$0.48 quarterly dividend declaration. See our latest analysis for Expedia Group. Despite a sharp 1 day share price drop of 9.02% and a year to date share price decline of 18.72%, Expedia Group still carries a 1 year total shareholder return of 38.63% and a 3 year total shareholder return of about 15x. This suggests that recent volatility sits against a much...

In April 2026, Park Hotels & Resorts reported first-quarter results showing sales of US$356 million and revenue of US$622 million, with net income of US$11 million compared with a net loss a year earlier. On the same day, the company slightly lowered its full-year 2026 earnings guidance, signaling more cautious expectations despite the return to profitability. We will now examine how Park’s improved quarterly profitability but trimmed full-year earnings outlook could influence the existing...

Centerspace (CSR) drew fresh attention after reporting Q1 2026 results that included lower sales, a wider net loss, and a reaffirmed outlook calling for flat to modest same-store revenue growth this year. See our latest analysis for Centerspace. The stock has had a mixed year, with a 30 day share price return of 5.84% and a 1 year total shareholder return of 16%. This suggests momentum has been building even as Q1 results and the ongoing review keep risks front of mind. If this kind of...

Earlier in May 2026, Everpure announced new Portworx capabilities for Red Hat OpenShift, including Plugin 2.2, Portworx Enterprise 3.6, and Portworx Backup 2.11, aimed at simplifying Kubernetes-native storage, backup, and disaster recovery for AI, container, and virtual machine workloads across hybrid and edge environments. This move deepens Everpure’s integration directly into the OpenShift console, making data management more accessible for enterprises standardizing on Kubernetes for...

In late April 2026, Unum Group reported first-quarter 2026 results showing higher revenue of US$3,355.2 million and net income of US$232 million, alongside completed share repurchases under two previously announced buyback programs totaling US$800 million and US$398.58 million. The combination of stronger earnings per share from continuing operations and meaningful reduction in shares outstanding underscores management’s focus on capital returns and earnings efficiency. With Unum’s recent...

Denali Therapeutics (DNLI) is back in focus after accelerated FDA approval of AVLAYAH, its first commercial product for neurologic Hunter syndrome in pediatric patients, with U.S. launch underway and initial payer discussions progressing. See our latest analysis for Denali Therapeutics. The AVLAYAH approval and pipeline updates come after a mixed share price pattern, with the stock up 20.59% year to date but longer term total shareholder returns still materially below earlier levels. This...

Ivanhoe Electric’s first-quarter 2026 results showed sales of US$858,000 and net income of US$41.74 million, a sharp turnaround from a net loss a year earlier, largely reflecting a very large gain from subsidiary Cordoba’s sale of the Alacrán copper-gold project. Alongside this profit swing, Ivanhoe Electric increased exploration spending at assets such as the Santa Cruz Copper Project and entered new copper-focused collaborations, including a partnership with SQM Chile, reshaping how...

In late April 2026, Sonoco Products Company filed a US$71.37 million shelf registration for 1,430,000 common shares tied to an ESOP-related offering. While the company recently reported strong earnings, the reliance on unusual items and flagged warning signs has raised questions about the quality and durability of its profit profile. We’ll now explore how the ESOP-related share issuance and questions over earnings quality intersect with Sonoco’s existing investment narrative. Uncover the...

AbCellera Biologics recently reported its first-quarter results, following earlier analyst forecasts for a year-over-year revenue increase and continued loss-making per share, alongside fresh insider share purchases. Together with upcoming presentations at major healthcare conferences, the insider buying hints at internal confidence as the company advances its antibody and clinical manufacturing ambitions. With insider buying as a backdrop, we’ll now examine how this earnings update could...

Stifel Financial (SF) has drawn fresh investor attention after launching a dedicated Project Finance platform focused on energy and infrastructure. The platform offers development and construction lending, risk management, and advisory services for projects with established credit profiles. See our latest analysis for Stifel Financial. Recent moves, including the Project Finance launch and fresh common and preferred dividend declarations, come after the share price has slipped around 10.6%...

Board changes, dividend and guidance reset the conversation around PROG Holdings stock PROG Holdings (PRG) has packed several investor focused signals into a short window, combining a leadership reshuffle, a declared cash dividend and updated full year guidance alongside its latest quarterly results. See our latest analysis for PROG Holdings. Those board changes, the fresh quarterly dividend and the raised 2026 guidance have come alongside a 23.6% 1 month share price return to $36.34 and a...

In early May 2026, BioLife Solutions reported first‑quarter 2026 results showing revenue of US$27.5 million versus US$22.05 million a year earlier, with net income improving to US$1.19 million from a net loss of US$0.448 million and earnings per share rising to US$0.02. The company also reiterated its 2026 outlook, pointing to ongoing demand for its biopreservation media franchise, mid‑60% gross margin expectations, and a shift to full‑year GAAP profitability supported by a cash balance of...

Maze Therapeutics: What Recent Returns Say About Investor Expectations Maze Therapeutics (MAZE) has drawn investor attention after a mixed stretch of stock performance, including a gain of about 2.2% over the past day alongside declines over the past week and month. See our latest analysis for Maze Therapeutics. The recent 1-day share price return of 2.2% comes after a sharp 90-day share price decline of 46.19%, while the 1-year total shareholder return of 156.96% highlights how sentiment has...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see A10 Networks...

Fast entry rule change sharpens focus on Nasdaq 100 Nasdaq (NDAQ) has updated its index rules so newly listed large caps can join the Nasdaq 100 after just 15 trading days, a material shift for investors tracking tech heavy benchmarks. See our latest analysis for Nasdaq. The fast entry rule change comes as Nasdaq’s share price sits at US$88.91, with a 30 day share price return of 6.91% and a year to date share price decline of 8.02%. Longer term total shareholder returns of 11.44% over one...

In April 2026, CTS Corporation reported first-quarter 2026 results showing higher sales of US$139.23 million and net income of US$17.2 million year on year, completed a US$18.28 million buyback of 405,242 shares announced in November 2025, and narrowed its 2026 sales guidance range to US$560 million–US$580 million. Management also highlighted plans to continue pursuing acquisitions to enhance diversification and earnings quality, signaling an ongoing focus on capital deployment beyond...

Recent performance snapshot Ovintiv (OVV) has drawn attention after a mixed stretch for the stock, with a slight decline over the past week, a small gain over the past month, and a stronger move over the past 3 months. See our latest analysis for Ovintiv. At a share price of $57.83, Ovintiv has pulled back over the past week but still carries solid momentum, with a 30 day share price return of 3.1% and a 1 year total shareholder return of 56.03%. If you are comparing Ovintiv with other energy...

Recent share performance and business backdrop Heartland Express (HTLD) has drawn increased attention after a period of strong share performance, with the stock higher over the past month and past 3 months, prompting investors to revisit its trucking focused business. See our latest analysis for Heartland Express. That recent momentum builds on a wider upswing, with a 44.48% year to date share price return and a 49.70% total shareholder return over 1 year, contrasting with weaker 3 and 5 year...

Fox Corporation has reported its fiscal third-quarter 2026 results, with revenue of US$3,994 million and net income of US$166 million, down from US$4,371 million and US$346 million a year earlier, while basic earnings per share from continuing operations fell from US$0.75 to US$0.38. Beneath the headline revenue decline, Fox exceeded analyst expectations on both earnings and sales, supported by growing Tubi streaming activity, stronger distribution revenue, and record third-quarter...

Why NMI Holdings Stock Is Back On Investor Radars NMI Holdings (NMIH) has drawn fresh attention after its latest quarterly update, where management flagged year-over-year revenue growth, adjusted profit above Wall Street expectations, and firm demand across its mortgage insurance portfolio. See our latest analysis for NMI Holdings. The recent Q1 update and the BTIG housing conference appearance seem to have rekindled interest, with the stock posting a 5.17% 7 day share price return even as...

Brookfield Infrastructure Partners L.P. reported past first-quarter 2026 results with revenue rising to US$6,301 million from US$5,392 million, while limited partners recorded a net loss of US$86 million versus income of US$26 million and a basic loss per unit of US$0.20 from continuing operations. At the same time, the partnership increased funds from operations per unit by about 10% and affirmed a quarterly cash distribution of US$0.4550 per unit, highlighting the contrast between...

Jack Henry & Associates, Inc. ( NASDAQ:JKHY ) investors will be delighted, with the company turning in some strong...

ACV Auctions (ACVA) just reported first quarter 2026 results that exceeded revenue and profit expectations, alongside a new US$100 million share repurchase authorization, putting the stock on many investors’ watchlists. See our latest analysis for ACV Auctions. The latest earnings beat and US$100 million buyback have come after a period where momentum has been mixed, with a 30 day share price return of 48.04% but a 1 year total shareholder return that is down 61.85%. This suggests recent...

Primoris Services (PRIM) is back in focus after first quarter 2026 results showed lower sales and profit, tied largely to renewables project issues, and a shareholder rights investigation raised fresh questions around prior disclosures. See our latest analysis for Primoris Services. The Q1 2026 miss and lowered outlook have led to a sharp reset in expectations, with the stock down 43.5% over a 7 day share price return and weaker returns across recent months. However, the 1 year and multi year...